Residential exposure to radon has been considered an important environmental risk factor for lung cancer.
Since 1986, U.S. EPA has recommended that all dwellings below the third floor be tested for the presence of radon and be mitigated to reduce indoor radon in homes with levels exceeding 148 Bq m-3.
In order to evaluate the effectiveness of New York State Department of Health's efforts to increase public awareness about radon risk and to promote radon testing and mitigation in compliance with EPA's guideline, a statewide radon mitigation survey was conducted between September 1995 and January 1996 among New York State residents whose homes had radon levels equal to or greater than 148 Bq m-3 on the first floor (or above) living areas.
The survey found that about 60% of 1,113 participants had taken actions for radon mitigation.
The percentage of respondents who took actions to reduce radon levels in their homes increased with increasing education level as well as household income level.
The method of installing a powered system to provide more ventilation was a more effective mitigation method than opening widows/doors or sealing cracks/openings in the basement.
Mitigation performed by contractors was more effective in reducing radon levels than mitigation performed by residents.
The reasons for performing radon mitigation given by the majority of respondents were those strongly related to radon health risk. (...)
Mots-clés Pascal : Etats Unis, Amérique du Nord, Amérique, New York, Facteur risque, Tumeur maligne, Bronchopulmonaire, Radiocontamination, Radon, Irradiation ionisante, Bâtiment résidentiel, Education santé, Prévention, Evaluation, Courbe survie, Homme, Appareil respiratoire pathologie, Poumon pathologie, Bronche pathologie
Mots-clés Pascal anglais : United States, North America, America, New York, Risk factor, Malignant tumor, Bronchopulmonary, Radioactive contamination, Radon, Ionizing irradiation, Residential building, Health education, Prevention, Evaluation, Survival curve, Human, Respiratory disease, Lung disease, Bronchus disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0487198
Code Inist : 002B03M02. Création : 22/03/2000.